These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 76662)

  • 1. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
    Buchmeier MJ; Oldstone MB
    J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB; Tishon A; Buchmeier MJ
    J Immunol; 1983 Feb; 130(2):912-8. PubMed ID: 6217255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
    Thomsen AR; Volkert M; Marker O
    Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection.
    Moskophidis D; Lehmann-Grube F
    J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of viral strains and host genes in determining levels of immune complexes in a model system: implications for HIV infection.
    Tishon A; Salmi A; Ahmed R; Oldstone MB
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):963-9. PubMed ID: 1812945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of tolerance to a chronic viral infection.
    Jamieson BD; Somasundaram T; Ahmed R
    J Immunol; 1991 Nov; 147(10):3521-9. PubMed ID: 1940352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
    Zeller JC; Nguyen N; Southern PJ
    Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
    J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public, private and non-specific antibodies induced by non-cytopathic viral infections.
    Recher M; Hunziker L; Ciurea A; Harris N; Lang KS
    Curr Opin Microbiol; 2004 Aug; 7(4):426-33. PubMed ID: 15358263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.